Iovance Biotherapeutics Inc (IOVA)
8.24
+0.10
(+1.23%)
USD |
NASDAQ |
Nov 21, 16:00
8.20
-0.04
(-0.49%)
After-Hours: 20:00
Iovance Biotherapeutics Enterprise Value: 2.115B for Nov. 21, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 21, 2024 | 2.115B |
| November 20, 2024 | 2.084B |
| November 19, 2024 | 2.100B |
| November 18, 2024 | 2.173B |
| November 15, 2024 | 2.097B |
| November 14, 2024 | 2.222B |
| November 13, 2024 | 2.347B |
| November 12, 2024 | 2.557B |
| November 11, 2024 | 2.849B |
| November 08, 2024 | 2.830B |
| November 07, 2024 | 3.346B |
| November 06, 2024 | 3.304B |
| November 05, 2024 | 3.157B |
| November 04, 2024 | 3.090B |
| November 01, 2024 | 3.014B |
| October 31, 2024 | 2.784B |
| October 30, 2024 | 2.967B |
| October 29, 2024 | 2.896B |
| October 28, 2024 | 2.963B |
| October 25, 2024 | 2.854B |
| October 24, 2024 | 2.820B |
| October 23, 2024 | 2.595B |
| October 22, 2024 | 2.638B |
| October 21, 2024 | 2.625B |
| October 18, 2024 | 2.723B |
| Date | Value |
|---|---|
| October 17, 2024 | 2.702B |
| October 16, 2024 | 2.458B |
| October 15, 2024 | 2.525B |
| October 14, 2024 | 2.580B |
| October 11, 2024 | 2.571B |
| October 10, 2024 | 2.488B |
| October 09, 2024 | 2.531B |
| October 08, 2024 | 2.564B |
| October 07, 2024 | 2.647B |
| October 04, 2024 | 2.790B |
| October 03, 2024 | 2.577B |
| October 02, 2024 | 2.577B |
| October 01, 2024 | 2.452B |
| September 30, 2024 | 2.464B |
| September 27, 2024 | 2.505B |
| September 26, 2024 | 2.396B |
| September 25, 2024 | 2.387B |
| September 24, 2024 | 2.423B |
| September 23, 2024 | 2.520B |
| September 20, 2024 | 2.669B |
| September 19, 2024 | 2.730B |
| September 18, 2024 | 2.675B |
| September 17, 2024 | 2.751B |
| September 16, 2024 | 2.566B |
| September 13, 2024 | 2.727B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
483.88M
Minimum
Oct 19 2023
7.095B
Maximum
Feb 08 2021
2.570B
Average
2.407B
Median
Enterprise Value Benchmarks
| Perspective Therapeutics Inc | -63.40M |
| Electromed Inc | 223.55M |
| Xtant Medical Holdings Inc | 85.83M |
| Myomo Inc | 138.56M |
| Catheter Precision Inc | 3.891M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -83.54M |
| Revenue (Quarterly) | 58.55M |
| Total Expenses (Quarterly) | 147.62M |
| EPS Diluted (Quarterly) | -0.28 |
| Gross Profit Margin (Quarterly) | 31.99% |
| Profit Margin (Quarterly) | -142.7% |
| Earnings Yield | -18.08% |
| Normalized Earnings Yield | -18.08 |